Intensity Therapeutics Management
Management criteria checks 2/4
Intensity Therapeutics' CEO is Lew Bender, appointed in Apr 2012, has a tenure of 12.58 years. total yearly compensation is $1.24M, comprised of 44.8% salary and 55.2% bonuses, including company stock and options. directly owns 14.67% of the company’s shares, worth $6.36M. The average tenure of the management team and the board of directors is 2.6 years and 7.5 years respectively.
Key information
Lew Bender
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 44.8% |
| CEO tenure | 12.6yrs |
| CEO ownership | 14.7% |
| Management average tenure | 2.6yrs |
| Board average tenure | 7.5yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$16m |
| Jun 30 2024 | n/a | n/a | -US$15m |
| Mar 31 2024 | n/a | n/a | -US$15m |
| Dec 31 2023 | US$1m | US$553k | -US$12m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$7m |
| Dec 31 2022 | US$995k | US$493k | -US$8m |
| Sep 30 2022 | n/a | n/a | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$9m |
| Dec 31 2021 | US$1m | US$434k | -US$8m |
| Sep 30 2021 | n/a | n/a | -US$7m |
| Jun 30 2021 | n/a | n/a | -US$7m |
| Mar 31 2021 | n/a | n/a | -US$6m |
| Dec 31 2020 | US$902k | US$410k | -US$6m |
Compensation vs Market: Lew's total compensation ($USD1.24M) is above average for companies of similar size in the US market ($USD651.40K).
Compensation vs Earnings: Lew's compensation has increased whilst the company is unprofitable.
CEO
Lew Bender (65 yo)
12.6yrs
Tenure
US$1,235,740
Compensation
Mr. Lewis H. Bender, also known as Lew, M.S., M.A., M.B.A., is the Founder of Intensity Therapeutics, Inc. and serves as its Chief Executive Officer and President since April 2012 and also serves as its Ch...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 12.6yrs | US$1.24m | 14.67% $ 6.4m | |
| Chief Financial Officer | less than a year | US$694.38k | no data | |
| Principal Accounting Officer & Controller | 7.7yrs | US$527.29k | 0.049% $ 21.1k | |
| Executive Vice President of Corporate Finance | 1.4yrs | US$75.09k | no data | |
| Executive Vice President of Clinical Development | 2.6yrs | no data | no data |
2.6yrs
Average Tenure
62yo
Average Age
Experienced Management: INTS's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | US$1.24m | 14.67% $ 6.4m | |
| Member of Scientific Advisory Board | 9.1yrs | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 6.5yrs | US$26.75k | 0% $ 0 | |
| Independent Director | 8.4yrs | US$31.75k | 0% $ 0 | |
| Member of Scientific Advisory Board | 9.1yrs | no data | no data | |
| Independent Director | 1.8yrs | US$28.75k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.5yrs
Average Tenure
63yo
Average Age
Experienced Board: INTS's board of directors are considered experienced (7.5 years average tenure).